Publicaciones
-
Vinent-Genestar J, Auvity S, Christiansen N, Ekelund H, Huys L, McNulty HBØ, Pani M, Pires V, Pourroy B and Stoner N.
European Association of Hospital Pharmacists (EAHP) guidance on the pharmacy handling of in vivo gene therapy medicinal products.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY . 31(5): 390-402.
-
López-Ramos MG, Vinent-Genestar J, Aarnoutse R, Colbers A, Velasco E, Martorell-Sampol L, Falcón-Neyra L, Neth O, Prieto L, Guillén S, Baquero-Artigao F, Méndez-Echevarría A, Gómez-Pastrana D, Jiménez AB, Lahoz R, Ramos-Amador JT, Soriano-Arandes A, Santiago B, Rosa Farré Riba, Fortuny-Guasch C, Soy D and Noguera-Julián A.
Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age
ANTIBIOTICS-BASEL . 12(2): .
-
Bossacoma F, Cuadrado-Vilanova M, Vinent-Genestar J, Correa MG, Gavrus D, Castillo H, Català-Mora J, Mora J, Schaiquevich P, Chantada G and Carcaboso AM.
Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection
OPHTHALMIC GENETICS . 41(4): 397-400. Nº de citas: 1
-
Moreno-Martínez ME, Vinent-Genestar J, Muñoz-Sánchez C and Carreras-Soler MJ.
Hospital pharmacist's roles and responsibilities with CAR-T medicines
FARMACIA HOSPITALARIA . 44(1): 26-31. Nº de citas: 10
-
Arenaza A, Diez R, Esteve J, Di Nicolantonio R, Gostkorzewicz J, Martínez C, Martínez Llinàs D, Martinez-Lopez J, Montesinos P, Moure-Fernández A, Sierra J and Vinent-Genestar J.
Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain
ClinicoEconomics and Outcomes Research . 11: 683-694. Nº de citas: 4
-
Parareda A, Català-Mora J, Carcaboso AM, Sola T, Cruz-Martínez O, Díaz J, Salvador-Hernandez H, de Torres C, Álvarez-Sampons A, Suñol M, Vinent-Genestar J, Guimaraens L, Prat-Bartomeu J and Mora J.
Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study
ACTA OPHTHALMOLOGICA . 92(3): 209-215. Nº de citas: 27